Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A

被引:559
作者
Harada, H
Becknell, B
Wilm, M
Mann, M
Huang, LJS
Taylor, SS
Scott, JD
Korsmeyer, SJ [1 ]
机构
[1] Washington Univ, Sch Med, Howard Hughes Med Inst, Div Mol Oncol, St Louis, MO 63110 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA
[4] Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97201 USA
[5] EMBL, Prot & Peptide Grp, Heidelberg, Germany
[6] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, Howard Hughes Med Inst, La Jolla, CA 92093 USA
关键词
D O I
10.1016/S1097-2765(00)80469-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling pathways between cell surface receptors and the BCL-2 family of proteins regulate cell death. Survival factors induce the phosphorylation and inactivation of BAD, a proapoptotic member. Purification of BAD kinase(s) identified membrane-based cAMP-dependent protein kinase (PKA) as a BAD Ser-112 (S112) site-specific kinase. PKA-specific inhibitors blocked the IL-3-induced phosphorylation on S112 of endogenous BAD as well as mitochondria-based BAD S112 kinase activity. A blocking peptide that disrupts type II PKA holoenzyme association with A-kinase-anchoring proteins (AKAPs) also inhibited BAD phosphorylation and eliminated the BAD S112 kinase activity at mitochondria. Thus, the anchoring of PKA to mitochondria represents a focused subcellular kinase/substrate interaction that inactivates BAD at its target organelle in response to a survival factor.
引用
收藏
页码:413 / 422
页数:10
相关论文
共 53 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] Role of translocation in the activation and function of protein kinase B
    Andjelkovic, M
    Alessi, DR
    Meier, R
    Fernandez, A
    Lamb, NJC
    Frech, M
    Cron, P
    Cohen, P
    Lucocq, JM
    Hemmings, BA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) : 31515 - 31524
  • [3] BERRIDGE MV, 1993, EXP HEMATOL, V21, P269
  • [4] The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136
    Blume-Jensen, P
    Janknecht, R
    Hunter, T
    [J]. CURRENT BIOLOGY, 1998, 8 (13) : 779 - 782
  • [5] BOYD JM, 1995, ONCOGENE, V11, P1921
  • [6] CARR DW, 1992, J BIOL CHEM, V267, P13376
  • [7] COLEMAN DL, 1989, J IMMUNOL, V143, P4134
  • [8] The C-elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9
    Conradt, B
    Horvitz, HR
    [J]. CELL, 1998, 93 (04) : 519 - 529
  • [9] Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
    Datta, SR
    Dudek, H
    Tao, X
    Masters, S
    Fu, HA
    Gotoh, Y
    Greenberg, ME
    [J]. CELL, 1997, 91 (02) : 231 - 241
  • [10] DEJONG D, 1994, CANCER RES, V54, P256